DYNAVAX
Live / Registered — Registered (as of 30 Jul 2024)
What this means for you
Registered since 30 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97518585
- Registration number
- 7463995
- Mark type
- Word mark
- Filed
- 25 Jul 2022
- Published for opposition
- 07 Nov 2023
- Registered
- 30 Jul 2024
- Attorney of record
- Beth M. Goldman
Goods and services
- Class 042 — Scientific and technological services: Medical, scientific, pharmaceutical, and biological research and product development consultation; medical, scientific, pharmaceutical, and biological research and product development for others; medical, scientific, pharmaceutical, biological, vaccine, and vaccine adjuvant research and development; medical testing, namely, providing medical testing services in the field of immunopharmaceuticals, vaccines and vaccine adjuvants and in the field of research relating to hepatitis, viruses and other infectious diseases, inflammatory diseases, genetic diseases, neurological diseases, autoimmune diseases, and cancer; testing for scientific research purposes, namely, pharmaceutical testing services
Owner
- Dynavax Technologies Corporation, Emeryville, CA, US
- Dynavax Technologies Corporation, Emeryville, CA, US
- Dynavax Technologies Corporation, Emeryville, CA, US
Prior registrations
Prosecution history
- 30 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 26 Jun 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jun 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 May 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Apr 2024 — NON-FINAL ACTION E-MAILED
- 24 Apr 2024 — SU - NON-FINAL ACTION - WRITTEN
- 27 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Feb 2024 — USE AMENDMENT FILED
- 24 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 02 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT